Published in Trends Biotechnol on November 08, 2007
Mistranslation of membrane proteins and two-component system activation trigger antibiotic-mediated cell death. Cell (2008) 4.47
Genome-scale identification of resistance functions in Pseudomonas aeruginosa using Tn-seq. MBio (2011) 2.13
Silver enhances antibiotic activity against gram-negative bacteria. Sci Transl Med (2013) 1.97
Antibiotic sensitivity profiles determined with an Escherichia coli gene knockout collection: generating an antibiotic bar code. Antimicrob Agents Chemother (2010) 1.78
Ecology and evolution as targets: the need for novel eco-evo drugs and strategies to fight antibiotic resistance. Antimicrob Agents Chemother (2011) 1.40
Targeting a bacterial stress response to enhance antibiotic action. Proc Natl Acad Sci U S A (2009) 1.39
Combination therapies for combating antimicrobial resistance. Curr Opin Microbiol (2011) 1.37
Staphylococcus aureus persisters tolerant to bactericidal antibiotics. J Mol Microbiol Biotechnol (2012) 1.25
The impact of different antibiotic regimens on the emergence of antimicrobial-resistant bacteria. PLoS One (2008) 1.12
A systems biology approach to identify effective cocktail drugs. BMC Syst Biol (2010) 1.11
Combination therapy with lysin CF-301 and antibiotic is superior to antibiotic alone for treating methicillin-resistant Staphylococcus aureus-induced murine bacteremia. J Infect Dis (2013) 1.09
Prediction of resistance development against drug combinations by collateral responses to component drugs. Sci Transl Med (2014) 1.09
Antagonism between bacteriostatic and bactericidal antibiotics is prevalent. Antimicrob Agents Chemother (2014) 1.01
Inhibitors of RecA activity discovered by high-throughput screening: cell-permeable small molecules attenuate the SOS response in Escherichia coli. J Biomol Screen (2009) 1.01
Synergistic drug combinations for tuberculosis therapy identified by a novel high-throughput screen. Antimicrob Agents Chemother (2011) 1.00
A window of opportunity to control the bacterial pathogen Pseudomonas aeruginosa combining antibiotics and phages. PLoS One (2014) 0.92
Novel Inhibitors of E. coli RecA ATPase Activity. Curr Chem Genomics (2010) 0.91
Discovery of antibiotic adjuvants. Nat Biotechnol (2013) 0.91
Single-gene deletion mutants of Escherichia coli with altered sensitivity to bicyclomycin, an inhibitor of transcription termination factor Rho. J Bacteriol (2011) 0.88
A novel point mutation promotes growth phase-dependent daptomycin tolerance in Staphylococcus aureus. Antimicrob Agents Chemother (2015) 0.88
The aminoglycoside antibiotic kanamycin damages DNA bases in Escherichia coli: caffeine potentiates the DNA-damaging effects of kanamycin while suppressing cell killing by ciprofloxacin in Escherichia coli and Bacillus anthracis. Antimicrob Agents Chemother (2012) 0.87
Synergy of nitric oxide and silver sulfadiazine against gram-negative, gram-positive, and antibiotic-resistant pathogens. Mol Pharm (2010) 0.86
Synergistic interactions of vancomycin with different antibiotics against Escherichia coli: trimethoprim and nitrofurantoin display strong synergies with vancomycin against wild-type E. coli. Antimicrob Agents Chemother (2014) 0.83
Deoxycytidine deaminase-deficient Escherichia coli strains display acute sensitivity to cytidine, adenosine, and guanosine and increased sensitivity to a range of antibiotics, including vancomycin. J Bacteriol (2014) 0.80
Maggot metabolites and their combinatory effects with antibiotic on Staphylococcus aureus. Ann Clin Microbiol Antimicrob (2011) 0.80
Bactericidal antibiotic-phytochemical combinations against methicillin resistant Staphylococcus aureus. Braz J Microbiol (2012) 0.78
Predicting the influence of multiple components on microbial inhibition using a logistic response model--a novel approach. BMC Complement Altern Med (2014) 0.78
Targeting zinc homeostasis to combat Aspergillus fumigatus infections. Front Microbiol (2015) 0.77
LiF Reduces MICs of Antibiotics against Clinical Isolates of Gram-Positive and Gram-Negative Bacteria. Int J Microbiol (2012) 0.77
Pairwise antibiotic interactions in Escherichia coli: triclosan, rifampicin and aztreonam with nine other classes of antibiotics. J Antibiot (Tokyo) (2016) 0.75
Simulating Serial-Target Antibacterial Drug Synergies Using Flux Balance Analysis. PLoS One (2016) 0.75
Investigation of antimicrobial use at a tertiary care hospital in Southern Punjab, Pakistan using WHO methodology. Antimicrob Resist Infect Control (2017) 0.75
Suppressive drug combinations and their potential to combat antibiotic resistance. J Antibiot (Tokyo) (2017) 0.75
Commercial Essential Oils as Potential Antimicrobials to Treat Skin Diseases. Evid Based Complement Alternat Med (2017) 0.75
Initial sequencing and comparative analysis of the mouse genome. Nature (2002) 96.15
Large-scale mapping and validation of Escherichia coli transcriptional regulation from a compendium of expression profiles. PLoS Biol (2007) 10.46
Mistranslation of membrane proteins and two-component system activation trigger antibiotic-mediated cell death. Cell (2008) 4.47
Discovering drug mode of action using reverse-engineered gene networks. Conf Proc IEEE Eng Med Biol Soc (2005) 0.76